Type 2 diabetes mellitus (T2DM) has reached epidemic proportions worldwide. Coronary artery disease (CAD) is one of the most important causes of mortality worldwide. In this regard, measurement of circulating biomarkers has been observed as an option for assessing risk for events beyond standard risk factors.
(2023). Assessment of Pro-Neurotensin as a Predictor of Coronary Artery Disease Among Patients with Type 2 Diabetes Mellitus. Egyptian Society of Diabetes and Lipidology Journal, 3(1), -. doi: 10.21608/esdlj.2023.456146
MLA
. "Assessment of Pro-Neurotensin as a Predictor of Coronary Artery Disease Among Patients with Type 2 Diabetes Mellitus", Egyptian Society of Diabetes and Lipidology Journal, 3, 1, 2023, -. doi: 10.21608/esdlj.2023.456146
HARVARD
(2023). 'Assessment of Pro-Neurotensin as a Predictor of Coronary Artery Disease Among Patients with Type 2 Diabetes Mellitus', Egyptian Society of Diabetes and Lipidology Journal, 3(1), pp. -. doi: 10.21608/esdlj.2023.456146
VANCOUVER
Assessment of Pro-Neurotensin as a Predictor of Coronary Artery Disease Among Patients with Type 2 Diabetes Mellitus. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(1): -. doi: 10.21608/esdlj.2023.456146
)
